Marlies Sproll

Statistics

Publications

Citations

243

H-Index

Active since

1996

Affiliations

Boehringer Ingelheim (Austria)(Current)

Boehringer Ingelheim (Egypt)

Amsterdam UMC Location Vrije Universiteit Amsterdam

Marlies Sproll is an author at Boehringer Ingelheim (Austria) specializing in therapeutic monoclonal antibodies, molecular oncology, and cd44 targeting.

Publications per year

1996–2002

Publications

Characterization of a high-affinity monoclonal antibody specific for CD44v6 as candidate for immunotherapy of squamous cell carcinomas

K-H Heider, Marlies Sproll, S. Susani et al. · Cancer Immunology Immunotherapy · 1996 · 83 citations

Life Sciences, Cell Biology, Oncology +14

Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head‐and‐neck cancer xenografts

Iris Verel, Karl‐Heinz Heider, Miranda Siegmund et al. · International Journal of Cancer · 2002 · 82 citations · Full text

Pharmacy, Molecular Biology, Oncology +17

Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.

Joep W. G. Stroomer, Jan C. Roos, Marlies Sproll et al. · PubMed · 2000 · 78 citations

Medicine, Nuclear Medicine, Oncology +17

1–3 of 3